Liver fibrosis is a common symptom of non-alcoholic steatohepatitis (NASH) and a worldwide clinical issue. The miR-122/HIF-1α signalling pathway is believed to play an important role in the genesis of progressive fibrosis. Isochlorogenic acid B (ICAB), naturally isolated from Laggera alata, is verified to have antioxidative and hepatoprotective properties. The aim of this study was to investigate the effect of ICAB on liver fibrosis in NASH and its potential protective mechanisms.
| INTRODUCTION
Non-alcoholic fatty liver disease (NAFLD) refers to a spectrum of hepatic diseases from simple fatty liver to nonalcoholic steatohepatitis (NASH), cirrhosis and hepatocellular carcinoma, and is observed in patients with no history of excessive alcohol consumption. NAFLD is now regarded as one of the most common liver diseases worldwide. It is estimated that about 20% of the general adult population of most westernized countries have hepatic steatosis and that approximately 5% of adults even suffer from NASH. [1] [2] [3] Although NASH accounts for a lower proportion, patients with NASH are much easier to progress to cirrhosis, liver failure and hepatocellular carcinoma. 4 However, besides liver transplantation, there is no medical therapy approved currently for NASH. 5 Liver fibrosis is one of the pathogenesis of NASH, and it is the pathological process of the transition from chronic liver disease to cirrhosis. For patients in the early stages of NASH, approximately 33% will progress to advanced fibrosis over 5-10 years. 6 There is also no medical therapy approved by FDA for liver fibrosis by now. Thus, it is urgent to develop new drugs to reduce or reverse fibrosis for the therapy of NASH. Recent publications demonstrated that microRNAs played an important role in the development of liver fibrosis. 7 MicroRNAs are small, non-coding RNAs which regulate the expression of numerous target genes at both transcriptional and translational levels. Altered microRNA profiles have been found in liver injury in both human and experimental animal models. 8 MicroRNA-122 (miR-122), the most abundant microRNA in the liver, constitutes about 70% of all microRNAs in mature hepatocytes, 9 and decreased levels of hepatic miR-122 has been found from patients as well as animals with ALD/NASH. [9] [10] [11] Besides, mice with germline and liver-specific deletion of miR-122 developed steatosis, fibrosis and hepatocellular carcinoma. 12 These results declared the essential functions of miR-122 in liver fibrosis.
In addition, hypoxia-inducible factor-1 (HIF-1), which is one of the targets of hepatic miR-122, 10 is an important regulator of pro-fibrotic mediator production. HIF-1 is composed of a stable HIF-1β subunit and a labile HIF-1α subunit. Previous studies revealed that HIF-1α was able to up-regulate the expressions of monocyte chemoattractant protein-1 (MCP-1), lysyloxidase-1(LOX-1), vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), tissue inhibitor of metalloproteinase (TIMPs) and connective tissue growth factor (CTGF), which all play crucial roles in fibrogenesis. [13] [14] [15] [16] Isochlorogenic acid B (ICAB, Figure 1 ) is naturally isolated from Laggera alata (Asteraceae). Laggera alata is mainly distributed in tropical Africa and South-East Asia and has been used as a folk medicine in China for over three hundred years, especially for the treatment of some ailments associated with hepatitis. 17 ICAB has been shown to have antioxidative, DNA protective, neuroprotective and hepatoprotective properties, 18, 19 but there is no specific evidence illustrating its effect on NASH and the related mechanisms. The purpose of this study was to investigate the effect of ICAB on liver fibrosis in NASH of mice and clarify the related mechanisms.
| MATERIALS AND METHODS

| Reagents
Isochlorogenic acid B was provided by Shanghai Yuan Ye Bio-Technology Co. (purity >99%). Alanine aminotransferase (ALT), aspartate aminotransferase (AST), total cholesterol (CHO), total cholesterol (TG), malondialdehyde (MDA), antioxidant enzymes including catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GSHPx) and glutathione (GSH) assay kits were the products of Nanjing Jian Cheng Bioengineering Institute (Nanjing, China). Silymarin (SM), antibodies against α-smooth muscle actin (α-SMA) and β-actin were purchased from Sigma (St Louis, MO, USA). All other antibodies were purchased from Cell Signaling Technology (Beverly, MA, USA). Real-time PCR master mix was purchased from Roche (Indianapolis, IN, USA). ABI TaqMan primers/probes were purchased from Applied Biosystems (Foster City, CA, USA). Qiagen miRNeasy kit was the products of Qiagen Sciences (Valencia, CA, USA). Deionized water was produced by a Milli Q Water Purification system from Millipore (MA, USA). Other chemicals were of analytical grade and were obtained from the local market.
| Treatment of animals
Male C57BL/6 mice weighing 18~22 g were obtained from the Beijing Vital River Experimental Animal Co., Ltd. (Beijing, China). The animals were maintained at 22°C with a 12-hour light/dark cycle and had free access to rodent chow and tap water. All the animal procedures were reviewed and approved by the Institutional Animal Care and Use Committee of the Peking Union Medical Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College. Efforts were made to minimize the pain and discomfort of mice. C57BL/6 mice were randomly divided into 7 groups (n = 8 per group), fed and treated as follows for 4 weeks: (a) mice in the control group fed with a control normal chow diet (A02082003B, Research Diets, New Brunswick, USA); (b) mice in the ICAB control group fed with the control normal chow diet and a daily oral gavage of ICAB (20 mg/kg); (c) mice in the model group fed with a methionine and choline-deficient (MCD) diet (A020-82002B, Research Diets, New Brunswick, USA); (d) mice in ICAB-treated groups fed with a MCD diet and a daily oral gavage of different doses of ICAB (5, 10 or 20 mg/ kg); and (e) mice in the SM-treated group fed with a MCD diet and a daily oral gavage of SM (10 mg/kg). On the last day, the animals were killed by decapitation after 12 hour of food deprivation. Blood samples were collected, and serum was obtained by centrifugation (1200 g, 15 minutes) and stored at −20°C until analyses were performed. A piece of liver tissue was rapidly dissected and then cut and fixed in formaldehyde saline (10%) solution for the histological analysis. The rest of the liver tissues were snap-frozen in liquid nitrogen and then stored at −80°C until use.
| Biochemical analysis
Serum ALT, AST, TG and CHO contents were analysed using commercial kits according to the manufacturer's protocols.
| Liver histopathological study
Liver tissues were fixed in formaldehyde saline (10%) solution and embedded in paraplast. Tissue sections (5 μm) were cut and stained by haematoxylin and eosin (H&E). Masson's trichrome or Sirius red staining were also carried out and examined microscopically for structural changes.
| Immunohistochemistry and immunofluorescence staining
Immunohistochemistry staining for α-SMA and immunofluorescence staining for Nrf2 and HIF-1α were performed on formalin-fixed, paraffin-embedded livers according to the manufacturer's instructions. Liver sections from eight mice per group were stained, and representative images are shown. Negative control staining was performed by incubating paraffin-embedded section without primary antibody.
| Quantitative real-time PCR
Total RNA of the hepatic tissues was extracted using Trizol reagent according to the supplier's instruction. RNA was quantified by optical density measurement at 260/ 280 nm using a spectrophotometer; 1 μg of total RNA was reverse-transcribed to cDNA using the PrimeScript ® RT reagent kit. And the levels of mRNA expression were quantified using an ABI prism 7500Sequence Detection System (Applied Biosystems, USA). The quantity of mRNA was normalized with the internal standard mouse β-actin. For miRNA analyses, total RNA was isolated using Qiagen miRNeasy kit with on column DNA digestion and RT-qPCR were performed using TaqMan miRNA assays (Ambion, Austin, TX, USA). The quantity of miR-122 was normalized to snoRNA202 expression, and the quantity of pri-miR-122 was normalized to GAPDH.
| Protein isolation and western blot
Liver tissues were homogenized in protein lysis buffer containing 1 mmol/L PMSF and then centrifuged at 20 000 g for 10 minutes at 4°C. After quantification of protein concentrations, the supernatants were mixed with Laemmli loading buffer, boiled for 4 minutes and then subjected to Western blot analysis. The membranes were blotted against the primary antibodies at 4°C for 16 hour, washed with 0.1% (v/v) Tween-20 in Tris-buffered saline (pH 7.4) and incubated with secondary antibodies for 45 minutes Protein bands were visualized by the enhanced chemiluminescence reaction method (Applygen Technologies Inc., Beijing, China). The densities of the bands were measured by the GelPro32 software program (Media Cybernetics, Marlow, UK).
| Statistical analysis
Data were expressed as means ± SD. Statistical analysis between two groups was performed by Student's t test, and multiple comparisons were performed by one-way ANOVA. P < 0.05 was considered statistically significant.
| RESULTS
| Effects of ICAB on MCD diet-induced NASH in mice
To determine whether ICAB has any beneficial effects on MCD diet-induced NASH, ICAB was orally administered to mice fed with MCD diet. In our experiment, the liver injury induced by MCD diet was indicated by the elevation of serum ALT and AST levels (240.81 ± 30.87 vs 40.68 ± 8.48, P < 0.001 and 400.84 ± 25.37 vs 100.36 ± 10.08, P < 0.001, respectively) ( Figure 2A ) and further verified by obvious hepatocyte ballooning and severe macrovesicular steatosis ( Figure 2B ). ICAB (5, 10 and 20 mg/kg) significantly reversed the increase in serum ALT and AST levels in a dose-dependent manner, while the liver pathological changes were also remarkably improved. SM (10 mg/kg) was used as a positive control drug in this experiment. It is noteworthy that ICAB exerted even better protective effect against liver injury induced by NASH than SM at the same dose. These observations suggested that ICAB had significant hepatoprotective effects on NASH induced by MCD diet in mice. In the meantime, no alterations on the above biochemical parameters and histomorphology were observed in mice treated by ICAB (20 mg/kg) alone.
| Effects of ICAB on hepatic TG and CHO contents in MCD diet-induced NASH mice
As hepatic lipid deposition is a key symptom of NASH, the effects of ICAB on hepatic TG and CHO contents were determined. As shown in Figure 3 , the levels of hepatic TG and CHO of mice with NASH were much higher than those in the control group. After treatment of ICAB, both the concentrations of TG and CHO were remarkedly and dose-dependently decreased. These results suggested that ICAB had obvious lipid-lowering effects against NASH induced by MCD diet in mice. Meanwhile, treatment of mice with ICAB (20 mg/kg) alone did not affect the hepatic contents of TG and CHO.
| Effect of ICAB on oxidative stress in MCD diet-induced NASH mice
The hepatic MDA level, as a marker of lipid peroxidation, was significantly increased in mice fed with MCD diet. In addition, the activities of liver antioxidant enzymes including CAT, SOD and GSH-Px were also reduced in mice with NASH. ICAB showed a significant inhibition on the formation of hepatic MDA and the depletion of liver glutathione (GSH) contents, as well as the reduction in antioxidant enzymes to the certain extents (Table 1) .
| Effects of ICAB on liver fibrosis in MCD diet-induced NASH mice
Mice with NASH induced by MCD diet had been previously reported to have marked hepatic fibrosis. 20, 21 As shown in Figure 4D , the content of hepatic Hyp, an important indicator of fibrosis, was significantly increased in mice fed with MCD diet in our experiment. The enhanced Sirius red and Masson's staining were also found in the liver of mice fed with MCD diet ( Figure 4A and B), which indicated collagen deposition. In addition, the expression of hepatic α-SMA was also remarkably upregulated, suggesting the hepatic stellate cell (HSC) ### P < 0.001 vs control group; *P < 0.05, **P < 0.05,***P < 0.001 vs methionine-and choline-deficient (MCD) group F I G U R E 3 Effects of isochlorogenic acid B (ICAB) on the elevation of hepatic triglyceride (TG) (A) and cholesterol (CHO) (B) contents in non-alcoholic steatohepatitis (NASH) mice. Data were expressed as means ± SD (n = 8). ###P < 0.001 vs control group; **P < 0.01, ***P < 0.001 vs methionineand choline-deficient (MCD) group activation and hepatic fibrosis development ( Figure 4A and C). The protective effect of ICAB against liver fibrosis was indicated by attenuating the up-regulation of hepatic α-SMA and inhibiting the increase in hepatic Hyp content. Sirius red and Masson's staining of the liver sections further confirmed the protective effect of ICAB against liver fibrosis ( Figure 4A and B) . Therefore, the above results indicated that the beneficial effect of ICAB on MCD dietinduced NASH might partially result from its ability to reduce liver fibrosis by limiting HSC activation and collagen deposition.
| Effects of ICAB on the expression of hepatic Nrf2 and its nuclear translocation in MCD diet-induced NASH mice
It was found that the protein expression of Nrf2 was very low in the mice of the control group. Mice on MCD diet for 4 weeks resulted in a slight increase in the protein expression of Nrf2, but with no statistical significance as compared with control group. Treatment of mice with different doses of ICAB significantly and dose-dependently up-regulated the protein expression of both nuclear and ### P < 0.001 vs control group; *P < 0.05, **P < 0.05, ***P < 0.001 vs methionine-and choline-deficient (MCD) group total Nrf2( Figure 5C and D) , and immunofluorescence assay further showed that ICAB treatment promoted the nuclear translocation of Nrf2 in the mice liver( Figure 5A and B). In addition, no alterations were found in the expression of hepatic Nrf2 and its nuclear translocation of the mice in the ICAB control group.
T A B L E 1 Influence of isochlorogenic acid B (ICAB) on liver glutathione (GSH), malondialdehyde (MDA) contents and superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px) activities in non-alcoholic steatohepatitis (NASH) mice
Groups
| Effects of ICAB on the expressions of hepatic genes involved in liver fibrosis in MCD diet-induced NASH mice
To assess the effects of ICAB on the expressions of genes associated with liver fibrosis, we detected the hepatic mRNA expressions of LOX, TGF-β1, MCP-1, COL1α1 and TIMP-1 in mice. Treatment of mice with MCD diet led to significant changes in the expressions of fibrosis-related genes. As shown in Figure 6 , the hepatic mRNA expressions of LOX, TGF-β1,MCP-1,COL1α1 and TIMP-1 were all significantly up-regulated in NASH mice. ICAB treatment resulted in a remarkable reduction in the expression of the genes related to fibrosis. Meanwhile, the gene expression was not changed in the mice of the ICAB control group.
| Effects of ICAB on the transcription of hepatic miR-122 in MCD diet-induced NASH mice
Previous research has revealed that reduced miR-122 had a pathogenic role in steatohepatitis. 10 Our results showed a marked 51.61% and 49.33% decrease in pri-miR-122 and miR-122 in the NASH mice compared with the normal group, and the reduction in pri-miR-122 and miR-122 can be reversed by the treatment of ICAB (10 and 20 mg/kg) ( Figure 7 ).
| Effects of ICAB on the expression of hepatic HIF-1α and its nuclear translocation in MCD diet-induced NASH mice
A remarkable increase in the protein expression of HIF-1α in MCD diet-induced NASH mice was found from the Western blot analysis results in our experiment, and ICAB treatment could dose-dependently inhibit the up-regulation of hepatic HIF-1α expression ( Figure 8C ). Immunofluorescence assay further showed that treatment of ICAB inhibited the nuclear translocation of hepatic HIF-1α in NASH mice ( Figure 8A and B).
| DISCUSSION
Isochlorogenic acid B is naturally isolated from Laggera alata. In southwestern China, this plant has been used as a folk medicine for some hundred years, especially in the treatment of some ailments associated with inflammation, including hepatitis. 17 Previous studies indicated that ICAB possessed protective effects against liver injury. 22, 23 In particular, ICAB (dicaffeoylquinic acid) had better antioxidative activity than chlorogenic acid (caffeoylquinic acid), which is a well-known major active component of Laggera alata investigated extensively and proved to have protective effect against liver fibrosis. 24,25 However, whether ICAB can attenuate liver fibrosis had not been studied yet.
The results of the present study demonstrated that mice on a MCD diet for 4 weeks could induce obvious NASH as evidenced by the elevation of serum ALT and AST F I G U R E 6 Effects of isochlorogenic acid B (ICAB) on the expressions of hepatic genes involved in liver fibrosis in non-alcoholic steatohepatitis (NASH) mice. Data were expressed as mean ± SD (n = 8).
## P < 0.05, ### P < 0.001 vs control group; *P < 0.05, **P < 0.05, ***P < 0.001 vs methionine-and cholinedeficient (MCD) group F I G U R E 7 Effects of isochlorogenic acid B (ICAB) on the transcription of hepatic pri-miR-122 (A) and miR-122 (B) in non-alcoholic steatohepatitis (NASH) mice. Data were expressed as mean ± SD (n = 8), ### P < 0.001 vs control group; *P < 0.05, ***P < 0.001 vs methionineand choline-deficient (MCD) group levels as well as liver pathological changes. Treatment of ICAB exhibited significant protective effect against NASH by attenuating the elevated ALT, AST, TG and CHO levels in a dose-dependent manner, while histopathological changes were also remarkably improved by ICAB treatment. Furthermore, our results illustrated that administration of ICAB from 5 to 20 mg/kg could remarkably attenuate the degree of fibrosis as evidenced by the changes of Sirius red and Masson's staining and its inhibitory effect on the expression of α-SMA, a specific marker of activated HSCs in the progression of liver fibrosis, and the antifibrotic effect was enhanced as the dose increased.
Liver fibrosis is a histological hallmark of liver injury; it can lead to severe hepatic dysfunctions and even lifethreatening conditions such as liver cirrhosis and hepatocarcinoma. 26 The mechanism of liver fibrosis is multifaceted.
Oxidative stress is a key factor in liver fibrosis. Previous studies clarified that free radicals produced under the condition of oxidative stress can exert chemical damage to lipids, proteins and carbohydrates and are related to liver fibrosis. In this study, we found that the proper balance between oxidant and antioxidant system was disturbed in the condition of NASH as indicated by the increase in liver MDA formation, and depletion of liver GSH as well as the antioxidant enzymes including SOD, CAT and GSH-Px. ICAB treatment remarkably inhibited the increase in hepatic MDA level and the decrease in liver GSH level as well as the activities of antioxidant enzymes, which suggested F I G U R E 8 Effects of isochlorogenic acid B (ICAB) on the expression of hepatic HIF-1α and its nuclear translocation. (A) Fluorescent micrographs of HIF-1α-loaded liver section (scale bar = 50 μmol/L); (B) fluorescence intensity using spectrometer; (C) hepatic expression of HIF-1α in mice determined by Western blot. Data were expressed as mean ± SD (n = 8), ### P < 0.001 vs control group; **P < 0.01, ***P < 0.001 vs methionine-and choline-deficient (MCD) group that the disturbance in oxidant and antioxidant system was reversed by ICAB treatment to a certain extent.
Notably, both the inhibition of lipid peroxidation and up-regulation of the antioxidant enzymes activities in vivo are regulated by Nrf2, a key regulator of oxidative stress in numerous cell types including hepatocytes. 27 Under normal conditions, Nrf2 is located on the cytoplasm and coupled with its repressor Kelch-like ECH2-associated protein as an inactive complex. However, under oxidative stress, the phosphorylation of Nrf2 leads to its dissociation from Keap1 and subsequent translocation to the nucleus where it binds to antioxidant response element (ARE), promotes the expression of Nrf2 target genes, and then increases the effect of antioxidative enzymes, such as CAT, SOD and GSH-Px. 28, 29 Therefore, up-regulation of Nrf2 and promotion of its nuclear translocation can decrease the reactive metabolites level and, correspondingly, attenuate tissue injury. In our study, Western blot analysis results revealed that mice fed with MCD diet showed an increase in the Nrf2 protein expression, but not statistically significantly as compared with control group. Treatment of mice with different doses of ICAB significantly and dose-dependently up-regulated the protein expression of both nuclear and total Nrf2, and immunofluorescence assay further showed that ICAB treatment promoted the nuclear translocation of Nrf2 in the mice liver. Further, it was found that the level of Nrf2 expression was in a good correlation with the treatment of ICAB against liver fibrosis in NASH. These results illuminated that the enhanced expression of Nrf2 in the nuclear transplantation by ICAB was consistent with the increased activities of antioxidant enzymes and the protective effect against liver injury. However, the mechanisms of up-regulatory effect of Nrf2 by ICAB require further investigation. Similarly, caffeic acid, a natural polyphenolic compound which has been widely accepted as a hepatoprotective folk medicine, also exerts its hepatoprotective effects by inhibiting the oxidative stress via Nrf2 pathway. [30] [31] [32] MicroRNAs, a group of non-coding small RNA molecules, affect gene expressions by binding to the 3′-untranslated regions (3′-UTR) of the target mRNAs. The development of many diseases, including liver fibrosis, is caused by dysregulation of microRNAs. Key components of NASH pathogenesis including steatosis, inflammation and hepatocyte death are all regulated by miRNAs. 33 The decreased expression of miR-122 had been found in both alcoholic and non-alcoholic liver disease, and the reduction in hepatic miR-122 contributed to the up-regulation of HIF-1α, which targets the genes related with fibrosis and plays a role in NASH-induced liver fibrosis. 10 Of note, miR-122 restoration has been considered as a hepatocellular carcinoma therapy, where its loss has been reported. 9 Combined with our results, the up-regulation of miR-122
and down-regulation of HIF-1, and further inhibition of the expression of genes related to fibrogenesis by ICAB treatment seems to explain, at least in part, the therapeutic effects of ICAB on liver fibrosis in NASH in mice.
| CONCLUSIONS
Obvious NASH was observed after treatment of mice with MCD diet for 4 weeks. ICAB showed protective effect against NASH in mice to a certain extent. The protective action might be associated with its ability to attenuate oxidative stress via up-regulating Nrf2 and suppressing fibrogenic factors through miR-122/HIF-1α pathway.
